dexmedetomidine nasal spray group + long duration high voltage pulse RF therapy group for herpes zoster

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 16 Dec 2024: Trial started, NCT06978192
  2. 18 May 2025: Trial registered, NCT06978192

The trials

NCT06978192: Clinical Study on the Treatment of Herpes Zoster Pain With Dexmedetomidine Combined With Long-term High Voltage

State
Under way
Phase
Phase 2
People
92 planned
Started
16 Dec 2024
Primary completion
28 Feb 2026
Arms
HL-PRF +DNS
Results
None posted
  1. 16 Dec 2024: Trial started
  2. 18 May 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.